Tools commonly used in the Blood Tests industry for day-to-day tasks and operations.

• Hematology analyzers
• Blood gas analyzers
• Coagulation analyzers
• Chemistry analyzers
• Microscopes
• Centrifuges
• Pipettes
• Test tubes
• Needles
• Lancets
• Specimen collection containers
• Blood culture bottles
• Automated sample processing systems
• Quality control materials
• Calibration solutions
• Reagents
• Laboratory information management systems (LIMS)
• Electronic medical record (EMR) systems

Common products and services typical of NAICS Code 621511-02, illustrating the main business activities and contributions to the market.

• Complete blood count (CBC)
• Blood glucose test
• Lipid panel
• Basic metabolic panel (BMP)
• Comprehensive metabolic panel (CMP)
• Liver function tests (LFTs)
• Kidney function tests
• Thyroid function tests
• Blood clotting tests
• Blood typing and crossmatching
• Infectious disease testing (e.g. HIV, hepatitis)
• Cancer screening (e.g. prostate-specific antigen, CA-125)
• Allergy testing
• Iron studies
• Vitamin and mineral testing
• Therapeutic drug monitoring
• Blood alcohol testing
• Blood lead testing

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Clinical Laboratory Improvement Amendments (CLIA): CLIA regulates laboratory testing and requires clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing. The certification is based on the complexity of the tests performed and the level of risk to patients. CLIA certification is required for all laboratories that perform testing on human specimens for the purpose of diagnosis, prevention, or treatment of any disease or impairment.
• Medical Technologist Certification: Medical technologists are required to be certified by the American Society for Clinical Pathology (ASCP) or other certifying agencies. The certification ensures that the medical technologist has the necessary knowledge and skills to perform laboratory tests accurately and efficiently.
• Medical Laboratory Scientist Certification: Medical laboratory scientists are required to be certified by the American Society for Clinical Pathology (ASCP) or other certifying agencies. The certification ensures that the medical laboratory scientist has the necessary knowledge and skills to perform laboratory tests accurately and efficiently.
• Clinical Chemistry Certification: Clinical chemists are required to be certified by the American Board of Clinical Chemistry (ABCC) or other certifying agencies. The certification ensures that the clinical chemist has the necessary knowledge and skills to perform laboratory tests accurately and efficiently.
• Hematology Certification: Hematologists are required to be certified by the American Society of Hematology (ASH) or other certifying agencies. The certification ensures that the hematologist has the necessary knowledge and skills to perform laboratory tests accurately and efficiently.

A concise historical narrative of NAICS Code 621511-02 covering global milestones and recent developments within the United States.

• The history of the Blood Tests industry dates back to the early 20th century when the first blood test was developed to diagnose syphilis. In the 1940s, the discovery of blood typing and cross-matching revolutionized blood transfusions and made them safer. The 1950s saw the development of the first automated blood cell counter, which allowed for faster and more accurate blood tests. In the 1970s, the first home pregnancy test was introduced, which allowed women to test for pregnancy in the privacy of their own homes. In recent years, the Blood Tests industry has seen significant advancements in technology, such as the development of point-of-care testing devices that allow for faster and more convenient testing. Additionally, the industry has seen an increase in the use of genetic testing, which allows for more personalized and targeted medical treatments. In the United States, the Blood Tests industry has experienced significant growth in recent years due to an aging population and an increase in chronic diseases such as diabetes and heart disease. The industry has also seen an increase in demand for genetic testing, which has become more affordable and accessible to consumers. In 2019, the global market for blood testing was valued at $51.5 billion, with the United States accounting for a significant portion of that market. The COVID-19 pandemic has also had a significant impact on the industry, with an increase in demand for COVID-19 testing leading to a surge in growth for the industry. Overall, the Blood Tests industry has a bright future ahead, with continued advancements in technology and an increasing demand for personalized medical treatments.

The anticipated future trajectory of the NAICS 621511-02 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Growing

  The future outlook for the Blood Tests industry in the USA is positive. The industry is expected to grow due to the increasing demand for blood tests for various medical conditions. The aging population and the rise in chronic diseases such as diabetes and cancer are also expected to contribute to the growth of the industry. Additionally, technological advancements in blood testing equipment and procedures are expected to improve the accuracy and efficiency of blood tests, which will further drive the growth of the industry. However, the industry may face challenges such as increasing competition and regulatory changes that may affect the profitability of the industry.

Recent groundbreaking advancements and milestones in the Blood Tests industry, reflecting notable innovations that have reshaped its landscape.

• Development Of Non-Invasive Blood Tests: Non-invasive blood tests that use saliva or urine samples instead of blood are being developed. These tests are less invasive and more convenient for patients, which may increase the demand for blood tests.
• Use Of Artificial Intelligence In Blood Testing: Artificial intelligence is being used to analyze blood test results and provide more accurate diagnoses. This technology can also help identify patterns and trends in blood test results, which can be used to develop new treatments and therapies.
• Point-Of-Care Testing: Point-of-care testing allows blood tests to be performed outside of a laboratory setting, such as in a doctor's office or at home. This technology can provide faster results and improve patient outcomes.
• Development Of New Biomarkers: New biomarkers are being discovered that can be used to diagnose and monitor various medical conditions. These biomarkers can provide more accurate diagnoses and help develop new treatments.
• Personalized Medicine: Personalized medicine uses a patient's genetic information to develop personalized treatment plans. Blood tests are an important part of this process, as they can provide information about a patient's health and help identify the best treatment options.